Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer

Pathology Research and Practice

Volumn 210, Issue 12, 2014, Pages 893-896

  Laczmanska, Izabela ^a   Karpinski, Pawel ^a   Kozlowska, Joanna ^a   Bebenek, Marek ^b   Ramsey, David ^c   Sedziak, Tomasz ^b   Ziolkowski, Piotr ^a   Sasiadek, Maria M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Lower Silesian Oncology Center   (Poland)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Colorectal cancer; Protein tyrosine phosphatase

Indexed keywords

RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; B RAF KINASE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; PTPRM PROTEIN, HUMAN; PTPRQ PROTEIN, HUMAN; PTPRT PROTEIN, HUMAN; PTPRZ1 PROTEIN, HUMAN; RAS PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER TISSUE; CHROMOSOME 18P; CHROMOSOME 20Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL SURGERY; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONCOGENE; ONCOGENE BRAF; ONCOGENE K RAS; PHENOTYPE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR LIKE GENE; PTPRM GENE; PTPRQ GENE; PTPRT GENE; PTPRZ1 GENE; TUMOR SUPPRESSOR GENE; VERY ELDERLY; ADENOCARCINOMA; CHROMOSOME 18; CHROMOSOME 20; COLORECTAL TUMOR; ENZYMOLOGY; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 20; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; TUMOR MARKERS, BIOLOGICAL;

EID: 84921860799     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.07.010     Document Type: Article

References (17)

1. Baudis M. Progenetix Oncogenomic Online Resource 2013, www.progenetix.net.
2. Burnett-Hartman A.N., Newcomb P.A., Potter J.D., Passarelli M.N., Phipps A.I., Wurscher M.A., Grady W.M., Zhu L.C., Upton M.P., Makar K.W. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res. 2013, 73(9):2863-2872.
3. Cai H., Kumar N., Ai N., Gupta S., Rath P., Baudis M. Progenetix: 12 years of oncogenomic data curation. Nucleic Acids Res. 2014, 42:1055-1062.
4. Fearon E.R. Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 2011, 6:479-507.
5. Geigl J.B., Obenauf A.C., Schwarzbraun T., Speicher M.R. Defining 'chromosomal instability'. Trends Genet. 2008, 24:64-69.
6. Gurzu S., Szentirmay Z., Toth E., Bara T., Bara T., Jung.F I. Serrated pathway adenocarcinomas: molecular and immunohistochemical insights into their recognition. PLoS ONE 2013, 8(3):e57699.
7. Hardy S., Julien S.G., Tremblay M.L. Impact of oncogenic protein tyrosine phosphatases in cancer. Anticancer Agents Med. Chem. 2012, 12:4-18.
8. Julien S.G., Dubé N., Hardy S., Tremblay M.L. Inside the human cancer tyrosine phosphatome. Nat. Rev. Cancer 2011, 11:35-49.
9. Karpinski P., Szmida E., Misiak B., Ramsey D., Leszczynski P., Bebenek M., Sedziak T., Grzebieniak Z., Jonkisz A., Lebioda A., Sasiadek M.M. Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis. Mol. Carcinog. 2012, 51:1003-1008.
10. Korff S., Woerner S.M., Yuan Y.P., Bork P., von Knebel Doeberitz M., Gebert J. Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability. BMC Cancer 2008, 8:329.
11. Kozlowska J., Karpinski P., Szmida E., Laczmanska I., Misiak B., Ramsey D., Bebenek M., Kielan W., Pesz K.A., Sasiadek M.M. Assessment of chromosomal imbalances in CIMP-high and CIMP-low/CIMP-0 colorectal cancers. Tumor Biol. 2012, 33:1015-1019.
12. Laczmanska I., Karpinski P., Bebenek M., Sedziak T., Ramsey D., Szmida E., Sasiadek M.M. Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer. J. Hum. Genet. 2013, 58:11-15.
13. Landau M.S., Kuan S.F., Chiosea S., Pai R.K. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression. Hum. Pathol. 2014, pii:S0046-8177(14)00161-0.
14. Ruivenkamp C., Hermsen M., Postma C., Klous A., Baak J., Meijer G., Demant P. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene 2003, 22:3472-3474.
15. Wang Z., Shen D., Parsons D.W., Bardelli A., Sager J., Szabo S., et al. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004, 304:1164-1166.
16. Wozniak M., Gamian E., Laczmanska I., Sasiadek M.M., Dus-Szachniewicz K., Ziolkowski P. Immunohistochemical and Western blot analysis of two protein tyrosine phosphatase receptors R and Z1, in colorectal carcinoma, colon adenoma and normal colon tissues. Histol. Histopathol. 2013, 18.
17. Yang L., Belaguli N., Berger D.H. MicroRNA and colorectal cancer. World J. Surg. 2009, 33:638-646.